Indiana University

TOLREMO Welcomes Dr. Alan Sandler to Scientific Advisory Board

Retrieved on: 
Mercoledì, Maggio 8, 2024
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Executive, SAB, Publication, Professor, Abstract, Drug resistance, Vanderbilt University, Internal medicine, Roche, Genentech, Doctor of Philosophy, Rush Medical College, Mirati Therapeutics, Mirati, Indiana University, Senior, CBP, Therapy, Assistant, Drug development, Bristol Myers Squibb, Associate, Division, Pharmaceutical industry

TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Alan Sandler, M.D., to its Scientific Advisory Board (SAB).

Key Points: 
  • TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Alan Sandler, M.D., to its Scientific Advisory Board (SAB).
  • The company’s lead candidate, TT125-802, is a small molecule CBP/p300 bromodomain inhibitor currently advancing through a Phase 1 clinical trial.
  • “Alan brings extensive experience in drug development, including clinical development experience with one of the leading KRAS inhibitors,” said Stefanie Flückiger-Mangual, PhD, Co-founder and Chief Executive Officer of TOLREMO.
  • The team has discovered an exciting pivotal mechanism that governs critical transcriptional resistance pathways,” said Alan Sandler, M.D., Scientific Advisory Board member at TOLREMO.

Premera Blue Cross Names Dr. Romilla Batra as Chief Medical Officer, Senior Vice President

Retrieved on: 
Giovedì, Maggio 2, 2024
UCLA, University of California, Irvine, University, Premera Blue Cross, Pacific Northwest, Health equity, Population health, Business administration, Business, SCAN, Indiana University, Senior, Medicare, SCAN Health Plan, Nursing

MOUNTLAKE TERRACE, Wash., May 2, 2024 /PRNewswire/ -- Premera Blue Cross, a leading health plan in the Pacific Northwest, today announced Dr. Romilla Batra joined the company as Senior Vice President and Chief Medical Officer.

Key Points: 
  • MOUNTLAKE TERRACE, Wash., May 2, 2024 /PRNewswire/ -- Premera Blue Cross, a leading health plan in the Pacific Northwest, today announced Dr. Romilla Batra joined the company as Senior Vice President and Chief Medical Officer.
  • "Romilla brings a profound understanding of clinical strategy and an enduring commitment to improve the member experience, making her an excellent choice as our new Chief Medical Officer," said Lee McGrath, Executive Vice President of Healthcare Services, Premera Blue Cross.
  • Dr. Batra has accountability for the company's clinical strategy, focused on making healthcare work better for Premera members and improving the provider experience.
  • She served as their Chief Medical Officer for nearly nine years where she was accountable for SCAN's overall clinical strategy and operations.

PROPEL Announces a Series of Executive, Senior Leaders to Advance Efforts to Empower Historically Black Colleges and Universities Nationwide

Retrieved on: 
Mercoledì, Maggio 1, 2024
Education, Ecosystem, Broccoli City Festival, Pearson Education, Indiana University Bloomington, Conference, Business, University of Georgia, Business administration, Art, Journalism, Indiana University, Faculty, North Carolina Central University, Wilberforce University, Apple, PROPEL, Howard University, HBCU, Student, Government, Morehouse College, Management

ATLANTA, May 1, 2024 /PRNewswire/ -- PROPEL Center, a first-of-its-kind innovation hub designed to support and advance the work of Historically Black Colleges and Universities (HBCUs) nationwide, announces the hiring of executive-level leaders and key program directors.

Key Points: 
  • ATLANTA, May 1, 2024 /PRNewswire/ -- PROPEL Center, a first-of-its-kind innovation hub designed to support and advance the work of Historically Black Colleges and Universities (HBCUs) nationwide, announces the hiring of executive-level leaders and key program directors.
  • Michael Johnson joins PROPEL Center as chief of staff and will oversee the planning and execution of all administrative and operational functions while ensuring accountability and delivering key performance indicators (KPIs).
  • Chief Development Officer Dr. Glen Spencer, Jr. will cultivate new industry, government and strategic relationships on behalf of PROPEL Center.
  • In collaboration with Spencer's work leading development objectives, Director of Strategic Partnerships, Ashley Sutton will guide PROPEL's partner engagement outcomes.

Ten Oaks Group Welcomes Bennett Cook and Alex Ney as Operating Partners

Retrieved on: 
Mercoledì, Maggio 1, 2024
Sale, CFO, EY, Software as a service, Private equity, Cornell University, CPA, Indiana University, Operating partner, Record, MBA, Colgate University, Bain Capital, Growth

CHARLOTTE, N.C., May 1, 2024 /PRNewswire/ -- Ten Oaks Group, a leading family office specializing in corporate carve-outs, is excited to announce the appointment of Bennett Cook and Alex Ney as Operating Partners.

Key Points: 
  • CHARLOTTE, N.C., May 1, 2024 /PRNewswire/ -- Ten Oaks Group, a leading family office specializing in corporate carve-outs, is excited to announce the appointment of Bennett Cook and Alex Ney as Operating Partners.
  • Alex Ney brings a strong background in financial advisory and operational improvement to Ten Oaks Group.
  • "We are delighted to welcome Bennett and Alex to the Ten Oaks team," said Curtis Griner, Managing Partner at Ten Oaks Group.
  • The addition of Bennett Cook and Alex Ney as Operating Partners underscores Ten Oaks Group's commitment to strengthening its operational capabilities and driving the value creation process at the company's portfolio companies.

Qualtrics X4 Kicks Off in Salt Lake City

Retrieved on: 
Mercoledì, Maggio 1, 2024
Mayo Clinic, Backstreet Boys, State, AI, Ally Financial, TMT, Intelligence, Indiana University, Mass General Brigham, Enterprise, XM, Adidas, OpenAI, Salt Palace, NBA, Financial services, Stanford University Medical Center, Delta, DoorDash, Owens Corning, WorkJam, Porsche, Education, Certification, Book, Cisco, Driscoll's, Commercial software, Johnson & Johnson, Customer experience, Collection, American Express, Organization, Government, CX, Bain & Company, Health care, Shake Shack, Kickstarter, Growth, Fortune 500, Management

SALT LAKE  CITY, May 1, 2024 /PRNewswire/ -- QUALTRICS X4 -- Qualtrics, the leader and creator of the experience management category, today announced the official kickoff of X4®: The Experience Management Summit. The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City. The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.

Key Points: 
  • The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City.
  • The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.
  • "We have a fantastic line-up of visionary leaders who will inspire and prepare everyone at X4 to improve the experiences at their own organizations," said Qualtrics CEO Zig Serafin.
  • "X4 is a can't-miss event for executives, thought leaders and experience management professionals who are unlocking growth by creating emotional connections at scale with their customers and employees."

EC-Council University Ranked Top 10 in Online Masters of Cybersecurity by Fortune® Education

Retrieved on: 
Mercoledì, Aprile 17, 2024
Online, EC-Council, University, MSCS, CHFI, Curriculum, Duke University, Indiana University, National initiative, Faculty, CEH, Student, Specialization, Nursing

Albuquerque, New Mexico, April 17, 2024 (GLOBE NEWSWIRE) -- EC-Council University has been named in Fortune® elite ranking of the Best Online Master's in Cybersecurity for 2024, alongside esteemed institutions like the University of California – Berkeley, Duke University, Indiana University, and the University of Arizona.

Key Points: 
  • Albuquerque, New Mexico, April 17, 2024 (GLOBE NEWSWIRE) -- EC-Council University has been named in Fortune® elite ranking of the Best Online Master's in Cybersecurity for 2024, alongside esteemed institutions like the University of California – Berkeley, Duke University, Indiana University, and the University of Arizona.
  • With a 92% retention rate and graduating class of 100 students in 2022-2023, EC-Council University has the second largest cohort of students for its Master’s program in cybersecurity among Fortune® top 20.
  • Each specialization has well-defined job prospects, derived from the National Initiative of Cybersecurity Education (NICE) published by the National Institute of Standards and Technology.
  • Lata Bavisi, President of EC-Council University, expressed gratitude for the recognition, stating, "We are honored to have EC-Council University acknowledged by Fortune® in the top 10 of the online master's program in cybersecurity.

Syntec Optics (Nasdaq: OPTX) Announces Executive Changes to Support Growth Plan

Retrieved on: 
Lunedì, Aprile 15, 2024
University, Original equipment manufacturer, Harvard Business School, Engineering, Iowa State University, Indiana University, Robotics, MBA, Management

ROCHESTER, NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and technical instruments and defense and aerospace OEMs, announced today executive-level changes.

Key Points: 
  • ROCHESTER, NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and technical instruments and defense and aerospace OEMs, announced today executive-level changes.
  • These changes will support its manufacturing excellence for organic growth and build upon its strategic initiatives for future inorganic growth.
  • Mr. Joe Mohr has been appointed Chief Manufacturing Officer, responsible for Syntec Optics sales, business development and revenue growth, and customer manufacturing excellence.
  • The executive change allows Mr. Mohr to focus on manufacturing excellence and customer support, while Mr. Kapoor will focus on other strategic initiatives.

JDRF Celebrates Research Award Winners and Recognizes Type 1 Diabetes Research Leaders

Retrieved on: 
Giovedì, Aprile 18, 2024
Consensus, University, Type 1 diabetes, Diabetes, Person, Risk, Food, Research, JDRF, Immunotherapy, Endocrinology, Retinopathy, Disease, Indiana University, Medicine, Metabolism, Clinical trial, Petah Tikva, Pediatrics, AID, Medical Center, Pediatric endocrinology, Inborn errors of metabolism, Quality of life, Division, Growth, Pharmaceutical industry

NEW YORK, April 18, 2024 /PRNewswire/ -- JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to five outstanding leaders in T1D research whose impact has pushed JDRF's mission forward.

Key Points: 
  • NEW YORK, April 18, 2024 /PRNewswire/ -- JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to five outstanding leaders in T1D research whose impact has pushed JDRF's mission forward.
  • She began her career with a JDRF career development award to support one of her first research projects on insulin pump therapy in very young children with diabetes.
  • The award recognizes leaders and innovators of outstanding clinical and translational T1D research.
  • JDRF Research award recipients were recognized at a ceremony in New York City earlier in April 2024.

Denodo Partners with Google Cloud on the Future of Enterprise Innovation with New Data Virtualization and Generative AI Integration

Retrieved on: 
Lunedì, Aprile 8, 2024
Software, Networks, Data Analytics, Internet, Artificial Intelligence, Data Management, Professional Services, Technology, Cloud, Google Cloud, Organization, Health, Partnership, GOOGLE, RAG, Education, Bias, Indiana University, LLM, CLOUD, Telecommunications, Data management

GOOGLE CLOUD NEXT, Booth 1362 - Denodo , a leader in data management, announced a new integration of the Denodo Platform with Google Cloud’s Vertex AI as part of its partnership.

Key Points: 
  • GOOGLE CLOUD NEXT, Booth 1362 - Denodo , a leader in data management, announced a new integration of the Denodo Platform with Google Cloud’s Vertex AI as part of its partnership.
  • Powered by data virtualization , the Denodo Platform will work with Google Cloud to empower joint customers to drive innovative solutions by combining advanced logical data management capabilities with cutting-edge generative AI services while providing access to state-of-the-art large language models (LLM).
  • “Generative AI can significantly improve how businesses operate and benefit virtually every industry,” said Ritika Suri, Technology Partnerships director, at Google Cloud.
  • “This latest integration further sets the stage for enterprises to redefine the boundaries of innovation by unlocking new levels of business value through the power of data and generative AI.

GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors

Retrieved on: 
Martedì, Aprile 9, 2024
RCT, Radiation, Brain, Completion, Progression-free survival, Risk, Patient, Lung, SRT, Neoplasm, Research, Indiana University, Breast, Doctor of Philosophy, MD, Quality of life, Trial of the century, Clinical trial, Melanoma, Recurrence, FDA, Craniotomy, Randomized controlled trial, Medical imaging

TEMPE, Ariz., April 9, 2024 /PRNewswire/ -- GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the lives of patients with brain tumors, today announced it has enrolled the 100th patient in its ROADS clinical study. ROADS, or Radiation One and Done Study, is the randomized control trial (RCT) designed to compare FDA-cleared GammaTile with stereotactic radiotherapy (SRT).

Key Points: 
  • ROADS, or Radiation One and Done Study, is the randomized control trial (RCT) designed to compare FDA-cleared GammaTile with stereotactic radiotherapy (SRT).
  • Patients enrolled in the ROADS clinical trial are randomized into two treatment groups following craniotomy with brain metastasis tumor removal: GammaTile implant at the time of surgery versus post-operative SRT.
  • Enrollment in the Phase 3 trial has now surpassed half of the 180 planned patients.
  • Our dedication to the ROADS trial is fueled by our mission to furnish the highest caliber of clinical evidence through randomized trial research.